Enlight Biosciences - Top 20 VC deals of 2008

Enlight Biosciences, FierceBiotech's top venture capital deals of 2008Company: Enlight Biosciences
Based: Boston, MA
Amount: $39M

Investors: Pfizer, PureTech Ventures, Merck Capital Ventures

Scoop: Eli Lilly, Merck and Pfizer joined forces with PureTech Ventures to launch Enlight Biosciences, an unusual venture that will spin off new companies based on promising technology. Enlight has already launched Endra, a biotech company that's pursuing a new approach to medical imaging.

Enlight Biosciences - Top 20 VC deals of 2008
Read more on

Suggested Articles

NASH leaders weigh in on the need for a drug for the disease and the challenges in getting it to patients.

The $210 million fund began life by leading a $17 million series A round in Quellis Biosciences.

The nine-story building will house Amgen’s Bay Area employees when it opens early in 2022.